Related Experiment Video
Updated: Jul 15, 2026
Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model
Published on: February 3, 2021
Loss-of-function screening by randomized intracellular antibodies: identification of hnRNP-K as a potential target
Atsushi Inoue1, Shinya Y Sawata, Kazunari Taira
1National Institute of Advanced Industrial Science and Technology (AIST), Central 4, 1-1-1 Higashi, Tsukuba Science City 305-8562, Japan. a.inoue@aist.go.jp
Abstract:
We have developed a loss-of-function screening system on the basis of intracellular expression of single domain antibodies. We demonstrate its use in identification of potential targets of metastasis of human cancerous cells. Randomized intracellular antibodies were expressed in highly metastatic cells, and a derivative pool of cells with loss of migration phenotype in chemotaxis assay was isolated. Isolation of antibodies from cells with loss of migration phenotype and identification of their target proteins revealed the involvement of the heterogeneous nuclear ribonucleoprotein K (hnRNP-K), a multifunctional signaling protein, in metastasis. Furthermore, we found that the cytoplasmic accumulation of hnRNP-K is crucial for its role in metastasis. The results demonstrate (i) the advantages of our functional interference screening over the gene-knockouts and gene-silencing, (ii) hnRNP-K as a potential target of metastasis, and (iii) a potential anti-metastasis peptide validated in in vitro cell migration assays.
Insights
We developed a novel screening system using intracellular antibodies to identify metastasis targets in cancer cells. This method revealed heterogeneous nuclear ribonucleoprotein K (hnRNP-K) as a key player in cancer metastasis.
Area of Science:
- Molecular Biology
- Cancer Research
- Drug Discovery
Background:
- Metastasis is a complex process involving multiple cellular mechanisms.
- Identifying key molecular targets is crucial for developing effective anti-metastasis therapies.
Purpose of the Study:
- To develop and validate a novel loss-of-function screening system for identifying metastasis targets.
- To investigate the role of heterogeneous nuclear ribonucleoprotein K (hnRNP-K) in cancer cell metastasis.
Main Methods:
- Development of a screening system based on intracellular single-domain antibody expression.
- Isolation of cancer cell populations with reduced migration phenotype using chemotaxis assays.
- Identification of target proteins through antibody isolation and protein analysis.
Main Results:
- The screening system successfully identified functional targets involved in metastasis.
- Heterogeneous nuclear ribonucleoprotein K (hnRNP-K) was identified as a critical protein in cancer cell metastasis.
- Cytoplasmic accumulation of hnRNP-K was found to be essential for its metastatic role.
- A novel anti-metastasis peptide was validated in vitro.
Conclusions:
- The developed functional interference screening offers advantages over traditional gene-knockout/silencing methods.
- hnRNP-K is a promising therapeutic target for inhibiting cancer metastasis.
- The study provides a new platform for functional target identification and validation in cancer research.
